Raymond James & Associates’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$169K Sell
13,028
-6,043
-32% -$87.3K ﹤0.01% 3689
2024
Q2
$273K Sell
19,071
-5,417
-22% -$89K ﹤0.01% 3427
2024
Q1
$425K Sell
24,488
-1,393
-5% -$20.1K ﹤0.01% 3162
2023
Q4
$351K Sell
25,881
-11,700
-31% -$161K ﹤0.01% 3183
2023
Q3
$485K Sell
37,581
-168
-0.4% -$2.1K ﹤0.01% 2917
2023
Q2
$492K Sell
37,749
-2,551
-6% -$31.1K ﹤0.01% 2949
2023
Q1
$496K Buy
40,300
+23,756
+144% +$254K ﹤0.01% 2923
2022
Q4
$144K Sell
16,544
-4,400
-21% -$46.3K ﹤0.01% 3547
2022
Q3
$217K Sell
20,944
-28,449
-58% -$376K ﹤0.01% 3398
2022
Q2
$649K Buy
49,393
+22,784
+86% +$330K ﹤0.01% 2738
2022
Q1
$403K Buy
26,609
+1,702
+7% +$28.6K ﹤0.01% 3206
2021
Q4
$443K Sell
24,907
-52,248
-68% -$1.08M ﹤0.01% 3178
2021
Q3
$1.6M Sell
77,155
-10,668
-12% -$256K ﹤0.01% 2256
2021
Q2
$3.05M Sell
87,823
-15,141
-15% -$317K ﹤0.01% 1818
2021
Q1
$1.8M Buy
102,964
+5,054
+5% +$91.9K ﹤0.01% 2088
2020
Q4
$1.74M Buy
97,910
+33,235
+51% +$550K ﹤0.01% 1976
2020
Q3
$1M Buy
64,675
+5,132
+9% +$90.7K ﹤0.01% 2181
2020
Q2
$985K Buy
59,543
+44,588
+298% +$414K ﹤0.01% 2172
2020
Q1
$95K Sell
14,955
-37,665
-72% -$267K ﹤0.01% 3230
2019
Q4
$375K Sell
52,620
-820
-2% -$5K ﹤0.01% 2944
2019
Q3
$240K Buy
53,440
+2,024
+4% +$12.2K ﹤0.01% 3149
2019
Q2
$356K Sell
51,416
-910
-2% -$6.45K ﹤0.01% 2905
2019
Q1
$376K Buy
52,326
+339
+0.7% +$3.07K ﹤0.01% 2851
2018
Q4
$514K Sell
51,987
-339
-0.6% -$3.52K ﹤0.01% 2534
2018
Q3
$625K Sell
52,326
-7,161
-12% -$64.8K ﹤0.01% 2552
2018
Q2
$550K Buy
59,487
+40,176
+208% +$361K ﹤0.01% 2615
2018
Q1
$153K Sell
19,311
-3,916
-17% -$33K ﹤0.01% 3208
2017
Q4
$229K Sell
23,227
-1,808
-7% -$19.5K ﹤0.01% 2981
2017
Q3
$293K Sell
25,035
-2,403
-9% -$33.9K ﹤0.01% 2810
2017
Q2
$467K Sell
27,438
-17,414
-39% -$300K ﹤0.01% 2461
2017
Q1
$683K Buy
44,852
+532
+1% +$8.11K ﹤0.01% 2198
2016
Q4
$718K Sell
44,320
-5,541
-11% -$102K ﹤0.01% 2114
2016
Q3
$1.02M Sell
49,861
-9,509
-16% -$208K ﹤0.01% 1865
2016
Q2
$1.24M Sell
59,370
-2,149
-3% -$38.4K ﹤0.01% 1613
2016
Q1
$1.26M Buy
61,519
+12,223
+25% +$228K ﹤0.01% 1546
2015
Q4
$833K Buy
49,296
+9,039
+22% +$133K ﹤0.01% 1736
2015
Q3
$522K Sell
40,257
-1,986
-5% -$25.9K ﹤0.01% 1908
2015
Q2
$539K Buy
42,243
+12,619
+43% +$146K ﹤0.01% 2055
2015
Q1
$290K Sell
29,624
-8,541
-22% -$81.7K ﹤0.01% 2229
2014
Q4
$278K Buy
+38,165
New +$286K ﹤0.01% 2148
2014
Q3
Sell
-26,300
Closed -$294K 2229
2014
Q2
$294K Sell
26,300
-32,719
-55% -$387K ﹤0.01% 2056
2014
Q1
$663K Buy
59,019
+35,185
+148% +$362K ﹤0.01% 1649
2013
Q4
$247K Sell
23,834
-107
-0.4% -$956 ﹤0.01% 1905
2013
Q3
$202K Buy
+23,941
New +$207K ﹤0.01% 1898

Other funds holding SWBI

Raymond James & Associates's SWBI Position: Q3 2024 in Review

Raymond James & Associates reduced its Smith & Wesson (SWBI) stake by 32% in Q3 2024, selling an estimated $87.3K and leaving 13,028 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

Raymond James & Associates first reported a position in SWBI in Q3 2013 and has held it in 44 quarters since. The position peaked at $3.05M in Q2 2021. 190 funds tracked by Wall St. Rank hold SWBI as of Q3 2024.

  • Raymond James & Associates held 13,028 shares of Smith & Wesson worth $169K as of Q3 2024.
  • Raymond James & Associates sold 6,043 Smith & Wesson shares in Q3 2024, an estimated $87.3K.
  • Smith & Wesson made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3689 holding.
  • Raymond James & Associates first reported a position in Smith & Wesson in Q3 2013 and has held it in 44 quarters since.
  • Raymond James & Associates's Smith & Wesson position peaked at $3.05M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held Smith & Wesson as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.